Market Overview:
The global fecal testing device market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of gastrointestinal diseases, rising awareness about early diagnosis and treatment of these diseases, and technological advancements in fecal testing devices. Based on type, the global fecal testing device market is segmented into parasite test, fecal occult blood test (FOBT), and others. The FOBT segment is expected to account for the largest share of the global market in 2018 owing to its high usage for early detection of colorectal cancer. Based on application, the global market is segmented into laboratory, hospital, clinic, and others.
Product Definition:
A fecal testing device is a medical instrument that is used to test for the presence of fecal matter in a person's stool. The device is inserted into the rectum to collect a sample of feces, which can then be tested for various diseases or conditions. The importance of fecal testing devices lies in their ability to detect serious health problems at an early stage, when they are often easier to treat.
Parasite Test:
Parasite Test is used for detecting the number, type and location of intestinal parasites in the human body. It also helps to evaluate if there are any parasitic eggs or cysts present in the human body. This test can be performed on any person without causing any harm to himself. The only requirement for this test is a stool sample which can be collected at home with ease and without much difficulty.
Fecal Occult Blood Test:
Fecal occult blood test is a method used to detect the presence of blood in stool. This test is usually done after meals and during routine stools examination. It helps in detecting the bleeding diathesis, ulcerative colitis or Crohn's disease, liver diseases, pancreatic cancer or tumors as well as certain types of cancer (colorectal cancer).
Application Insights:
The others segment dominated the global market in terms of revenue in 2017. This is due to the high demand for non-invasive and minimally invasive tests that can be performed at home, thereby reducing costs associated with travel and accommodation. The laboratory application segment is expected to grow at a lucrative rate over the forecast period owing to an increase in demand for accurate diagnosis coupled with technological advancements such as online consultation services.
The hospital application segment was estimated as highest revenue-generating segment owing to an increase in number of hospitals offering diagnostic services along with advanced healthcare facilities equipped with state-of-the art technology. Furthermore, rising prevalence of diseases supported by large patient bases resulting in increasing need for frequent testing are some factors expected to drive growth over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of laboratories and diagnostic facilities coupled with high awareness levels pertaining to modern disease management practices are some factors attributing to the largest revenue share. Moreover, increasing government initiatives for testing individuals at-risk for parasitic infections is also expected to drive growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the coming years owing to rising prevalence rates of various infectious diseases such as malaria, dengue, chikungunya and filarial among others in this region. According to WHO estimates published in May 2018; more than 107 million people were affected by malaria across 21 countries within Asia Pacific region from 2015 - 2016 fiscal year (1). Such high prevalence rates have led researchers and healthcare professionals involved with fecal testing device development towards conducting clinical trials related toward these conditions which will further boost regional demand during forecast period.
Growth Factors:
- Increasing incidence of gastrointestinal diseases: The increasing incidence of gastrointestinal diseases is one of the key growth drivers for the fecal testing device market. According to a study by the World Health Organization (WHO), approximately 1.7 billion cases of diarrhea occur each year, resulting in the death of over 760,000 children below five years of age. This high incidence rate is expected to drive demand for fecal testing devices in the coming years.
- Rising awareness about gut health: There is a growing awareness among people about gut health and its importance in overall health and well-being. This has led to an increase in demand for diagnostic tests that can help assess gut health, such as fecal testing devices.
- Technological advancements: The development of new and innovative technologies has helped boost growth prospects for the fecal testing device market in recent years. For instance, portable and easy-to-use devices that do not require any laboratory setup are now available in the market, which is helping expand adoption rates among consumers worldwide..
Scope Of The Report
Report Attributes
Report Details
Report Title
Fecal Testing Device Market Research Report
By Type
Parasite Test, Fecal Occult Blood Test, Others
By Application
Laboratory, Hospital, Clinic, Others
By Companies
Atlas Biomed, EliTech, Boditech Med, Eurolyser, Thermo Fisher Scientific, RTA Laboratories, Teco Diagnostics, Humasis, Alfa Scientific Designs
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
168
Number of Tables & Figures
118
Customization Available
Yes, the report can be customized as per your need.
Global Fecal Testing Device Market Report Segments:
The global Fecal Testing Device market is segmented on the basis of:
Types
Parasite Test, Fecal Occult Blood Test, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Laboratory, Hospital, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Atlas Biomed
- EliTech
- Boditech Med
- Eurolyser
- Thermo Fisher Scientific
- RTA Laboratories
- Teco Diagnostics
- Humasis
- Alfa Scientific Designs
Highlights of The Fecal Testing Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Parasite Test
- Fecal Occult Blood Test
- Others
- By Application:
- Laboratory
- Hospital
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Fecal Testing Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A fecal testing device is a medical device that is used to test for the presence of fecal matter in the feces. This type of device can be used to diagnose various gastrointestinal diseases, such as Crohn's disease and ulcerative colitis.
Some of the major players in the fecal testing device market are Atlas Biomed, EliTech, Boditech Med, Eurolyser, Thermo Fisher Scientific, RTA Laboratories, Teco Diagnostics, Humasis, Alfa Scientific Designs.
The fecal testing device market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Fecal Testing Device Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Fecal Testing Device Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Fecal Testing Device Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Fecal Testing Device Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Fecal Testing Device Market Size & Forecast, 2018-2028
4.5.1 Fecal Testing Device Market Size and Y-o-Y Growth
4.5.2 Fecal Testing Device Market Absolute $ Opportunity
Chapter 5 Global Fecal Testing Device Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Fecal Testing Device Market Size Forecast by Type
5.2.1 Parasite Test
5.2.2 Fecal Occult Blood Test
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Fecal Testing Device Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Fecal Testing Device Market Size Forecast by Applications
6.2.1 Laboratory
6.2.2 Hospital
6.2.3 Clinic
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Fecal Testing Device Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Fecal Testing Device Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Fecal Testing Device Analysis and Forecast
9.1 Introduction
9.2 North America Fecal Testing Device Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Fecal Testing Device Market Size Forecast by Type
9.6.1 Parasite Test
9.6.2 Fecal Occult Blood Test
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Fecal Testing Device Market Size Forecast by Applications
9.10.1 Laboratory
9.10.2 Hospital
9.10.3 Clinic
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Fecal Testing Device Analysis and Forecast
10.1 Introduction
10.2 Europe Fecal Testing Device Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Fecal Testing Device Market Size Forecast by Type
10.6.1 Parasite Test
10.6.2 Fecal Occult Blood Test
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Fecal Testing Device Market Size Forecast by Applications
10.10.1 Laboratory
10.10.2 Hospital
10.10.3 Clinic
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Fecal Testing Device Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Fecal Testing Device Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Fecal Testing Device Market Size Forecast by Type
11.6.1 Parasite Test
11.6.2 Fecal Occult Blood Test
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Fecal Testing Device Market Size Forecast by Applications
11.10.1 Laboratory
11.10.2 Hospital
11.10.3 Clinic
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Fecal Testing Device Analysis and Forecast
12.1 Introduction
12.2 Latin America Fecal Testing Device Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Fecal Testing Device Market Size Forecast by Type
12.6.1 Parasite Test
12.6.2 Fecal Occult Blood Test
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Fecal Testing Device Market Size Forecast by Applications
12.10.1 Laboratory
12.10.2 Hospital
12.10.3 Clinic
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Fecal Testing Device Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Fecal Testing Device Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Fecal Testing Device Market Size Forecast by Type
13.6.1 Parasite Test
13.6.2 Fecal Occult Blood Test
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Fecal Testing Device Market Size Forecast by Applications
13.10.1 Laboratory
13.10.2 Hospital
13.10.3 Clinic
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Fecal Testing Device Market: Competitive Dashboard
14.2 Global Fecal Testing Device Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Atlas Biomed
14.3.2 EliTech
14.3.3 Boditech Med
14.3.4 Eurolyser
14.3.5 Thermo Fisher Scientific
14.3.6 RTA Laboratories
14.3.7 Teco Diagnostics
14.3.8 Humasis
14.3.9 Alfa Scientific Designs
